Micronutrient and Additive Modifications May Optimize Diet To Health

This is a prospective clinical intervention trial where patients with moderately active ulcerative colitis are randomized to either normal healthy diet or a diet with elimination of emulsifying agents within the E 400-group with special respect to carragenan, CMC and polysorbates. At study start and end after one month their diet, clinical characteristics and microbiota will be analysed. The hypotheses are that their disease activity measured with calprotectin and their microbiota will improve after intervention.

Inclusion Criteria:Ulcerative colitis, moderately active, stable medicationExclusion Criteria:Severe disease, recent surgery, proctitis, pregancy, treatment with antibiotics, difficulties in understanding the information about the study, multimorbidity that makes it impossible to participate